CA985172A - Compositions and methods for reducing blood cholesterol - Google Patents

Compositions and methods for reducing blood cholesterol

Info

Publication number
CA985172A
CA985172A CA153,515A CA153515A CA985172A CA 985172 A CA985172 A CA 985172A CA 153515 A CA153515 A CA 153515A CA 985172 A CA985172 A CA 985172A
Authority
CA
Canada
Prior art keywords
compositions
methods
reducing blood
blood cholesterol
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA153,515A
Other languages
English (en)
Other versions
CA153515S (fr
Inventor
Dushan M. Dvornik
Mitchell N. Cayen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Priority to CA153,515A priority Critical patent/CA985172A/en
Priority to ZA00737246A priority patent/ZA737246B/xx
Priority to US398130A priority patent/US3890438A/en
Priority to IE1698/73A priority patent/IE38274B1/xx
Priority to DE19732348176 priority patent/DE2348176A1/de
Priority to IN2210/CAL/73A priority patent/IN138921B/en
Priority to NL7313519A priority patent/NL7313519A/xx
Priority to BE136318A priority patent/BE805634A/xx
Priority to HUAE394A priority patent/HU169814B/hu
Priority to ES419355A priority patent/ES419355A1/es
Priority to GB4656473A priority patent/GB1439625A/en
Priority to CS736877A priority patent/CS197387B1/cs
Priority to SE7313618A priority patent/SE403886B/xx
Priority to FR7335748A priority patent/FR2201893B1/fr
Priority to DD173898A priority patent/DD106948A5/xx
Priority to AU61108/73A priority patent/AU477269B2/en
Application granted granted Critical
Publication of CA985172A publication Critical patent/CA985172A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CA153,515A 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol Expired CA985172A (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
CA153,515A CA985172A (en) 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol
ZA00737246A ZA737246B (en) 1972-10-06 1973-09-11 Compositions and methods for reducing blood cholesterol
US398130A US3890438A (en) 1972-10-06 1973-09-17 Compositions and methods for reducing blood cholesterol
IE1698/73A IE38274B1 (en) 1972-10-06 1973-09-24 Compositions for reducing blood cholesterol
DE19732348176 DE2348176A1 (de) 1972-10-06 1973-09-25 Arzneimittel zur erniedrigung des blutcholesterinspiegels
IN2210/CAL/73A IN138921B (de) 1972-10-06 1973-10-01
NL7313519A NL7313519A (de) 1972-10-06 1973-10-02
BE136318A BE805634A (fr) 1972-10-06 1973-10-03 Compositions et procedes pour abaisser le taux de cholesterol sanguin
HUAE394A HU169814B (de) 1972-10-06 1973-10-04
ES419355A ES419355A1 (es) 1972-10-06 1973-10-05 Un procedimiento para la preparacion de una composicion re-ductora del nivel de colesterol en la sangre.
GB4656473A GB1439625A (en) 1972-10-06 1973-10-05 Compositions for reducing blood cholesterol
CS736877A CS197387B1 (en) 1972-10-06 1973-10-05 Pharmaceutical mixture for decreasing the cholesterole level in the blood
SE7313618A SE403886B (sv) 1972-10-06 1973-10-05 Forfarande for framstellning av en farmaceutisk komposition for senkning av blodkolesterolnivan
FR7335748A FR2201893B1 (de) 1972-10-06 1973-10-05
DD173898A DD106948A5 (de) 1972-10-06 1973-10-05
AU61108/73A AU477269B2 (en) 1972-10-06 1973-10-08 Compositions and methods for reducing blood cholesterol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA153,515A CA985172A (en) 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol

Publications (1)

Publication Number Publication Date
CA985172A true CA985172A (en) 1976-03-09

Family

ID=4094630

Family Applications (1)

Application Number Title Priority Date Filing Date
CA153,515A Expired CA985172A (en) 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol

Country Status (16)

Country Link
US (1) US3890438A (de)
AU (1) AU477269B2 (de)
BE (1) BE805634A (de)
CA (1) CA985172A (de)
CS (1) CS197387B1 (de)
DD (1) DD106948A5 (de)
DE (1) DE2348176A1 (de)
ES (1) ES419355A1 (de)
FR (1) FR2201893B1 (de)
GB (1) GB1439625A (de)
HU (1) HU169814B (de)
IE (1) IE38274B1 (de)
IN (1) IN138921B (de)
NL (1) NL7313519A (de)
SE (1) SE403886B (de)
ZA (1) ZA737246B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838716A1 (de) * 1988-11-15 1990-05-17 Kanoldt Arzneimittel Gmbh Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
AU748138B2 (en) * 1998-03-26 2002-05-30 Phytopharm Plc. Steroidal sapogenins and their derivatives for treating alzheimers disease
US20030118673A1 (en) * 1998-03-26 2003-06-26 Zongqin Xia Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB2347676A (en) * 1999-03-08 2000-09-13 Phytopharm Plc Screening method
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
WO2003022287A1 (fr) * 2001-08-24 2003-03-20 Jilin Tianyao Science And Technology Co. Ltd. UTILISATION DE 3β-HYDROXY-5-SPIROSTENE POUR PREVENIR OU TRAITER DES MALADIES OU DES ETATS CARDIO-VASCULAIRES, INHIBER DES TUMEURS ET REDUIRE LES LIPIDES SANGUINS
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
AU2003231427A1 (en) * 2002-04-15 2003-10-27 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Compounds and preparation methods of carboxylate and monoester succinate derivative of diosgenin
GB0409567D0 (en) 2004-04-28 2004-06-02 Phytopharm Plc Chemical compounds
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
US20090209486A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions of carbohydrates as dietary supplements
US20090209489A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
US20090208588A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown GERD carbohydrate compositions
EP2595621A1 (de) 2010-07-20 2013-05-29 Phytopharm PLC Behandlung von l-dpa-, dopaminagonisten- und/oder dopaminverstärker-induzierten erkrankungen
FR3133158A1 (fr) 2022-03-04 2023-09-08 Psa Automobiles Sa Procédé de gestion énergetique d’une prise d’alimentation d’accessoire dans un véhicule automobile à l’arrêt

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630211A (de) * 1962-03-28

Also Published As

Publication number Publication date
GB1439625A (en) 1976-06-16
ES419355A1 (es) 1976-03-01
IN138921B (de) 1976-04-17
FR2201893A1 (de) 1974-05-03
DD106948A5 (de) 1974-07-12
FR2201893B1 (de) 1977-09-09
IE38274L (en) 1974-04-06
ZA737246B (en) 1975-04-30
NL7313519A (de) 1974-04-09
DE2348176A1 (de) 1974-04-11
HU169814B (de) 1977-02-28
IE38274B1 (en) 1978-02-01
AU6110873A (en) 1975-04-10
BE805634A (fr) 1974-04-03
US3890438A (en) 1975-06-17
AU477269B2 (en) 1976-10-21
SE403886B (sv) 1978-09-11
CS197387B1 (en) 1980-05-30

Similar Documents

Publication Publication Date Title
AU477269B2 (en) Compositions and methods for reducing blood cholesterol
CA971768A (en) Oximeter and method
CA1028953A (en) Compositions and methods for depressing blood serum cholesterol
AU470415B2 (en) Composition and process
CA1003631A (en) Antiozonant-antioxidant composition and process for preparation thereof
CA1023665A (en) Dermatological composition and method
CA993584A (en) Adhesive compositions and methods
AU468257B2 (en) Novel steroids and compositions
CA1014559A (en) Amino-imidazo and amino-pyrazolo-isoquinolines and process for the preparation thereof
AU471942B2 (en) Composition and process
CA1026334A (en) Nitroimidazolyl-triazolo-pyridazines and process for their preparation
AU5815373A (en) Compositions and methods
CA903429A (en) Method and compositions for cable-blocking
CA902628A (en) Silylorganocarbamates and preparation
CA902474A (en) Process and diagnostic composition
CA893251A (en) Diagnostic composition and process
CA903651A (en) Cholesterol determination
CA845160A (en) Cholesterol lowering agent and its preparation
CA850646A (en) Cholesterol lowering agent and its preparation
CA856831A (en) Cholesterol lowering agent and its preparation
CA908322A (en) Mattresses for clinical and other uses
CA1022290A (en) Copolymer-phyliosilicate composition and process therefor
CA909790A (en) Bis-chromonyl compounds and methods for their preparation
CA905057A (en) Fabric-stiffening composition and process
AU5144169A (en) Composition for lowering cholesterol blood